COST-EFFECTIVENESS OF CANNABIDIOL (CBD) FOR THE TREATMENT OF SEIZURES IN PATIENTS WITH TREATMENT-RESISTANT LENNOX-GASTAUT SYNDROME OR DRAVET SYNDROME IN THE NETHERLANDS

被引：0
|
作者：
Siddiqui, J. [1 ]
Bowditch, S. [2 ]
机构：
[1] FIECON Ltd, London, England
[2] Jazz Pharmaceut, London, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE400
引用
收藏
页码：S127 / S128
页数：2
相关论文
共 50 条
  • [1] Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome
    Lattanzi, S.
    Trinka, E.
    Russo, E.
    Striano, P.
    Citraro, R.
    Silvestrini, M.
    Brigo, F.
    [J]. DRUGS OF TODAY, 2019, 55 (03) : 177 - 196
  • [2] Cannabidiol for Treatment of Patients With Seizures Associated With Lennox-Gastaut Syndrome
    不详
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (04) : 546 - 546
  • [3] Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome
    Edward E. Neuberger
    Josh J. Carlson
    David L. Veenstra
    [J]. PharmacoEconomics, 2020, 38 : 1237 - 1245
  • [4] Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome
    Neuberger, Edward E.
    Carlson, Josh J.
    Veenstra, David L.
    [J]. PHARMACOECONOMICS, 2020, 38 (11) : 1237 - 1245
  • [5] The Curious Case of Lennox-Gastaut Syndrome: Treatment-Resistant Seizures in a Patient With Autism Spectrum Disease With Lennox-Gastaut Syndrome
    Anvekar, Priyanka
    Lohana, Petras
    Elmahal, Mohammed
    Ali, Syed R.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [6] Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome"
    Hollenack, Kelly
    Marshall, Jade
    [J]. PHARMACOECONOMICS, 2021, 39 (04) : 473 - 475
  • [7] Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
    Kelly Hollenack
    Jade Marshall
    [J]. PharmacoEconomics, 2021, 39 : 473 - 475
  • [8] Fenfluramine for the Treatment of Dravet Syndrome and Lennox-Gastaut Syndrome
    Balagura, Ganna
    Cacciatore, Marta
    Grasso, Eleonora A.
    Striano, Pasquale
    Verrotti, Alberto
    [J]. CNS DRUGS, 2020, 34 (10) : 1001 - 1007
  • [9] Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea
    Koo, Chung Mo
    Kim, Se Hee
    Lee, Joon Soo
    Park, Byung Joo
    Lee, Hae Kook
    Kim, Heung Dong
    Kang, Hoon Chul
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (50)
  • [10] Cost-effectiveness analysis of antiepileptic drugs in the treatment of Lennox-Gastaut syndrome
    Clements, Karen M.
    Skornicki, Michelle
    O'Sullivan, Amy K.
    [J]. EPILEPSY & BEHAVIOR, 2013, 29 (01) : 184 - 189
12345